Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?
Pacing and Clinical Electrophysiology · 2024
DOI: 10.1111/pace.14965 ↗At a glance
Fallbericht in Pacing and Clinical Electrophysiology, 2024. Written by Emile Voisine and 12 co-authors. Institution: Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Québec, Canada. Major MEDLINE topics: Sarcoidosis, Defibrillators, Implantable, Tachycardia, Ventricular, Fluorodeoxyglucose F18. Cited 3 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
A 40‐year‐old man, newly diagnosed with cardiac sarcoidosis (CS) presented with symptomatic ventricular tachycardia three days after starting steroid‐based immunosuppressive therapy (IT). There was no clear guideline indication for implantable cardioverter‐defibrillator (ICD) before the initiation of IT. Shortly after ICD implantation and the initiation of anti‐arrhythmic drugs, recurring ventricular arrhythmias required titration of the anti‐arrhythmic drug therapy. One‐year follow‐up assessment showed no significant arrhythmias and complete PET scan FDG uptake suppression. This case, along with recent publications, suggests transient pro‐arrhythmic effects of steroids in patients with CS, which are not appropriately addressed in the current guidelines. We believe ICD implantation should be considered in clinically manifest CS before initiating IT, particularly in cases with heterogeneous and/or extensive FDG uptake on PET scans.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Québec, Canada.
- Department of Cardiology, Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada.
- Arrhythmia Service, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
ORCID profiles: Emile Voisine, Jonathan Beaudoin
Cite
APA
Voisine, E., Lemay, S., Beaudoin, J., Jacob, P., Philippon, F., Marchand, L., Vallée-Marcotte, B., Bernier, F., Laliberté, C., Fortin, S., Komlosy, M. È., Birnie, D. H., & Sénéchal, M. (2024). Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14965
Vancouver
Voisine E, Lemay S, Beaudoin J, Jacob P, Philippon F, Marchand L, et al. Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.14965
BibTeX
@article{Voisine2024,
author = {Voisine, Emile and Lemay, Sylvain and Beaudoin, Jonathan and Jacob, Philippe and Philippon, François and Marchand, Laurie and Vallée-Marcotte, Bastien and Bernier, Florence and Laliberté, Claudine and Fortin, Sophie and Komlosy, Marie-Ève and Birnie, David H and Sénéchal, Mario},
title = {Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
doi = {10.1111/pace.14965}
}
EUVIMED